Inovio Pharmaceuticals Inc (INO): 11/4 CEPI announced the first funding aw...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	13
Posts	3218
Boards Moderated	0
Alias Born	04/26/2007

Lakers_w

Re: None

Saturday, 11/06/2021 5:23:34 PM

Saturday, November 06, 2021 5:23:34 PM

11/4 CEPI announced the first funding awards under its $200m programme to advance the development of vaccines that provide broad protection against SARS-CoV-2 variant. CEPI will support researchers at two institutions, MigVax Ltd, Israel, and the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization (VIDO), Canada

The awards announced today have been issued in response to a CEPI Call for Proposals issued in March 2021, and additional awards are expected to be announced shortly. The programme forms part of CEPI’s next 5-year plan, published in March, which aims to reduce or even eliminate the future risk of pandemics and epidemics.

Both projects aim to establish preclinical proof of concept for ‘variant-proof’ vaccines that protect against new COVID-19 variants of concern. The vaccine platforms may also be applicable for developing vaccines which are protective against a broad range of betacoronaviruses

https://cepi.net/news_cepi/cepi-announces-first-funding-awards-in-quest-to-develop-variant-proof-covid-19-vaccines/